Measles second dose vaccine utilization and associated factors among children aged 24–35 months in Sub-Saharan Africa, a multi-level analysis from recent DHS surveys

BACKGROUND: Although a safe and effective vaccine is available, measles remains an important cause of mortality and morbidity among young children in Sub-Saharan Africa (SSA). The WHO and UNICEF recommended measles-containing vaccine dose 2 (MCV2) in addition to measles-containing vaccine dose 1 (MC...

Descripción completa

Detalles Bibliográficos
Autores principales: Chilot, Dagmawi, Belay, Daniel Gashaneh, Shitu, Kegnie, Gela, Yibeltal Yismaw, Getnet, Mihret, Mulat, Bezawit, Muluneh, Atalay Goshu, Merid, Mehari Woldemariam, Bitew, Desalegn Anmut, Alem, Adugnaw Zeleke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9655865/
https://www.ncbi.nlm.nih.gov/pubmed/36371164
http://dx.doi.org/10.1186/s12889-022-14478-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9655865/
https://www.ncbi.nlm.nih.gov/pubmed/36371164
http://dx.doi.org/10.1186/s12889-022-14478-x

Ejemplares similares